Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis

The 1,3-beta-d-glucan (BDG) test is used for the diagnosis of invasive candidiasis (IC) in intensive care units (ICUs). However, its utility for patient management is unclear. This study assessed the impact of BDG test results on therapeutic decisions. This was a single-center observational study co...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Microbiol
Egile Nagusiak: Kritikos, Antonios, Poissy, Julien, Croxatto, Antony, Bochud, Pierre-Yves, Pagani, Jean-Luc, Lamoth, Frederic
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2020
Gaiak:
Mycology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269378/
https://ncbi.nlm.nih.gov/pubmed/32238435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01996-19
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak